动态增强MRI与超声早期预测乳腺癌新辅助化疗反应
该前瞻性研究纳入39例乳腺癌患者,在新辅助化疗前及化疗第一、二周期后分别行DCE-US和DCE-MRI检查,以Miller-Payne分级为参考标准。新辅助化疗后DCE-MRI的Ktrans和Kep参数在良好反应组与轻微反应组间存在差异,预测良好反应的AUC为0.76-0.81;DCE-US的RT变化百分比AUC为0.71。定量分析DCE-MRI和DCE-US有助于早期预测新辅助化疗反应。
要点
- 新辅助化疗后DCE-MRI的Ktrans和Kep参数对预测良好反应具有中等至良好诊断效能(AUC 0.76-0.81)。
- DCE-US的RT变化百分比对新辅助化疗反应具有中等预测效能(AUC 0.71)。
- 良好反应(MPG 4或5级)占30.8%,轻微反应(MPG 1-3级)占69.2%。
核心结论
- DCE-MRI和DCE-US的定量分析有助于早期预测乳腺癌新辅助化疗反应。
研究设计与样本
- 机构审查委员会批准的前瞻性研究,2014年至2016年纳入39例乳腺癌女性,在新辅助化疗前、第一周期后(DCE-US)和第二周期后(DCE-MRI)行检查,以术后Miller-Payne分级系统为参考标准。
诊断标准与关键数值
- 新辅助化疗后DCE-MRI的Ktrans和Kep的均值、第25、50、75百分位数在良好反应组与轻微反应组间存在差异,预测良好反应的AUC为0.76-0.81(p ≤ 0.007)。
- DCE-US的RT变化百分比预测良好反应的AUC为0.71(p = 0.023)。
- Miller-Payne分级:良好反应为MPG 4或5级(12例,30.8%),轻微反应为MPG 1-3级(27例,69.2%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and DCE ultrasound (DCE-US) for predicting response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
MATERIALS AND METHODS: This Institutional Review Board-approved prospective study was performed between 2014 and 2016. Thirty-nine women with breast cancer underwent DCE-US and DCE-MRI before the NAC, follow-up DCE-US after the first cycle of NAC, and follow-up DCE-MRI after the second cycle of NAC. DCE-MRI parameters (transfer constant [Ktrans], reverse constant [kep], and leakage space [Ve]) were assessed with histograms. From DCE-US, peak-enhancement, the area under the curve, wash-in rate, wash-out rate, time to peak, and rise time (RT) were obtained. After surgery, all the imaging parameters and their changes were compared with histopathologic response using the Miller-Payne Grading (MPG) system. Data from minor and good responders were compared using Wilcoxon rank sum test, chi-square test, or Fisher's exact test. Receiver operating characteristic curve analysis was used for assessing diagnostic performance to predict good response.
RESULTS: Twelve patients (30.8%) showed a good response (MPG 4 or 5) and 27 (69.2%) showed a minor response (MPG 1-3). The mean, 25th, 50th, and 75th percentiles of Ktrans and Kep of post-NAC DCE-MRI differed between the two groups. These parameters showed fair to good diagnostic performance for the prediction of response to NAC (AUC 0.76-0.81, p ≤ 0.007). Among DCE-US parameters, the percentage change in RT showed fair prediction (AUC 0.71, p = 0.023).
CONCLUSION: Quantitative analysis of DCE-MRI and DCE-US was helpful for early prediction of response to NAC.
引用
- Kim Y, Kim SH, Song BJ, et al. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer. Korean J Radiol. 2018. PMID: 29962874. doi:10.3348/kjr.2018.19.4.682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。